Tertiary Nav - Press Releases Press ReleasesMedia Statements Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 5/3/24 Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health 5/1/24 Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments 4/30/24 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 4/24/24 Sarepta Therapeutics to Announce First Quarter 2024 Financial Results 3/29/24 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 3/19/24 Sarepta Therapeutics Announces Call for Applications for the 2024 LGMD Grant Award Program 3/19/24 Sarepta Therapeutics anuncia la convocatoria de solicitudes para el Programa de concesión de subvenciones para LGMD 2024 3/4/24 Sarepta Therapeutics to Present at Upcoming Investor Conferences 2/29/24 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 2/29/24 Sarepta Therapeutics Announces Call for Applications for the 7th Annual Route 79, The Duchenne Scholarship Program Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last » Displaying 1 - 10 of 816 Toolkit Print Page | Email Alerts | RSS Feeds | Contacts
Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 5/3/24 Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health 5/1/24 Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments 4/30/24 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 4/24/24 Sarepta Therapeutics to Announce First Quarter 2024 Financial Results 3/29/24 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 3/19/24 Sarepta Therapeutics Announces Call for Applications for the 2024 LGMD Grant Award Program 3/19/24 Sarepta Therapeutics anuncia la convocatoria de solicitudes para el Programa de concesión de subvenciones para LGMD 2024 3/4/24 Sarepta Therapeutics to Present at Upcoming Investor Conferences 2/29/24 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 2/29/24 Sarepta Therapeutics Announces Call for Applications for the 7th Annual Route 79, The Duchenne Scholarship Program Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last » Displaying 1 - 10 of 816